AGC Biologics Appoints Whitney Sandberg as the new Vice President of Quality for its Colorado Facilities

Company News

AGC Biologics today announced Whitney Sandberg has been appointed as the company’s Vice President for Quality in Colorado. In this position she will have executive oversight for quality operations at the company’s two facilities in the state, located in Boulder and Longmont. Both facilities provide AGC Biologics critical resources for serving its global clientele, and Sandberg’s expertise will ensure each location produces products of the highest quality that meet global GMP requirements and industry expectations.

I-MAB Biopharma and AGC Biologics Partner on Late-Phase Project


AGC Biologics today announced a new partnership with I-MAB Biopharma (Nasdaq: IMAB). The I-MAB treatment being developed is approaching late-phase clinical trials and AGC Biologics will manufacture the materials at its site in Seattle, while also supporting the launch readiness of I-MAB’s product.

AGC Biologics Receives Transatlantic Award for Investments in Milan Biopharmaceutical Industry


AGC Biologics today announced it won the 2021 Transatlantic Award from the American Chamber of Commerce in Italy (AmCham). The company was named the 2021 winner for its investments in the Italian biopharmaceutical industry, which includes expansion at its Center of Excellence in Milan to make it a global hub for cell and gene therapy innovation, development and manufacturing.

4TEEN4 Pharmaceuticals Selects AGC Biologics to Manufacture Procizumab

News, Company News

AGC Biologics to produce Procizumab for early and late clinical Phases at the company’s Chiba and Copenhagen facilities

Follow Us
Join us on LinkedIn Follow us on Twitter